Abbvie Inc. vs Danaher Corporation
ABBV vs DHR — side-by-side comparison from reported financials. ABBV leads 6, DHR leads 4 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Danaher Corporation
DHR · Healthcare
$219.81+1.08%Mixed
| Metric | ABBV | DHR |
|---|---|---|
| Price | $276.43 | $219.81 |
| Market cap | $488B | $155B |
| Revenue (TTM) | $64.4B | $25.1B |
| Revenue growth | +1.8% | -2.7% |
| Net margin | 9.8% | 15.9% |
| Free cash flow | $18.2B | $5.47B |
| Net cash (debt) | ($56.2B) | ($13.8B) |
| 1-year price return | +19.8% | +7.5% |
| P/E | 77.4 | 38.6 |
| P/E vs own history (cheap-side %) | 23% | 38% |
| Dividend yield | 2.45% | 0.62% |
| Return on equity | 96% | 8% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 9 of 11 |
| Employees | 57,000 | 60,000 |
Full résumé-style profiles: ABBV CV · DHR CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.